26
UBS Evergreen Investment Plan Qiping Zhang, Peiyi Li, Ziyi Zhu

UBS Project Presentation

Embed Size (px)

Citation preview

Page 1: UBS Project Presentation

UBS Evergreen Investment PlanQiping Zhang, Peiyi Li, Ziyi Zhu

Page 2: UBS Project Presentation

General Terms

Issuer United Bank of Switzerland

Denomination AUD 250,000

Notional Amount AUD 100,000,000

Number of Notes 400 Notes

Issue Date 20 April 2016

Maturity Date 19 April 2021

Issue Price 100%

Interest Reset Period Annually

Interest Payment Dates 20 April in each year

Reference Rate Swap Rate of Australia

Principal 100%

Coupon (3+1)*Reference Rate - 3*2.31%

Australian Dollar Floating Rate Notes

Summary of indicative terms and conditions as of 8 April

2016

Page 3: UBS Project Presentation

Prospects : AUD –Linked Leveraged FRN

Australia Economy Forecast

Historical Australia Interest Rate

FRN will gain!

Stable growth

Interest rate expected to

increase

Inflation expected to

increase

Page 4: UBS Project Presentation

  Interest Rate FRN  6.000% 17.061%

  5.500% 15.061%

  5.000% 13.061%

  4.500% 11.061%

  4.000% 9.061%

 Forecast 3.500% 7.061%

⍟ Breakeven 2.269% 2.137%

Current 2.000% 1.061%

Floor 1.730% 0.000%

  1.500% 0.000%

  1.000% 0.000%

  0.500% 0.000%

Risk-Return Analysis: AUD –Linked Leveraged FRN

0

17.06%

1.73%

FRN

Zero Rate

2.14%

⍟When the interest rate > 2.269%, the annualized return is 2.137%, which is equal to Australian 5-year swap rate.

Page 5: UBS Project Presentation

General Terms

Issuer United Bank of Switzerland

Denomination ZAR 250,000

Notional Amount ZAR 100,000,000

Number of Notes 400 Notes

Issue Date 20 April 2016

Maturity Date 19 April 2021

Issue Price 100%

Interest Reset Period Annually

Interest Payment Dates 20 April in each year

Reference Rate Swap Rate of South Africa

Principal 100%

Coupon (2+1)*7.99%-2*Reference Rate

South Africa Rand Leveraged Inverse

Floating Rate Notes

Summary of indicative terms and conditions as of 12 April

2016

Page 6: UBS Project Presentation

Weak economy outlook• Expected to recover gradually

Inflation pressure

• Expected to drop

Prospects : ZAR –Linked Inverse FRN

2017 Inflation ForecastGrowth Forecast

Inverse FRN mitigate interest rate risk

Page 7: UBS Project Presentation

  Swap Rate Inverse FRN

  12.489% 0.000%

Cap 11.989% 0.000%

  10.042% 3.893%

  9.542% 4.893%

  9.042% 5.893%

  8.542% 6.893%

  8.042% 7.893%⍟ Breakeven  7.864% 8.250%

Current 7.542% 8.893%

  7.042% 9.893%

Forecast  6.542% 10.893%

  6.042% 11.893%

  5.542% 12.893%

Risk-Return Analysis: ZAR –Linked Inverse FRN

0

23.53%

11.989%

Inverse FRN

Zero Rate

8.25%

⍟When the swap rate = 7.864%, the annualized return is 8.25%, which is equal to South Africa 5-year swap rate.

Page 8: UBS Project Presentation

CNY 100% Capital Protected

SSE Composite Index -Linked Note

General Terms

Issuer United Bank of Switzerland

Denomination CNY 250,000 per Note

Notional Amount CNY 100,000,000

Number of Notes 400 Notes

Issue Price 100% of the Notional Amount

Issue Date 20 April 2016

Maturity Date 19 April 2021

Underlying Index ShangHai Stock Exchange Composite Index

Index Initial Level 3,023.65

Index Final Level Closing Level of the Index on Maturity Date

Option Type Digital Call Option

Strike Level 2,675.64

Final Redemption 100%+30%, if SCIT ≥2675.64 on Maturity Date

Min Redemption 100%

Summary of indicative terms and conditions as of 12 April

2016

* SCIT = Closing Level of SSE Composite Index on Maturity Date

Page 9: UBS Project Presentation

Exports Expansion

Moderate GDP

Growth

Economy Transition

BONUS GET!!!

Prospects :SSE Index -Linked Note

Page 10: UBS Project Presentation

Index Chg% Principal Return

3600.00 19.06% 130% 30%

3500.00 15.75% 130% 30%

3400.00 12.447% 130% 30%

3300.00 9.140% 130% 30%

3200.00 5.832% 130% 30%

3100.00 2.525% 130% 30%

Current 3023.65 0.000% 130% 30%

2900.00 -4.089% 130% 30%

2800.00 -7.397% 130% 30%

⍟Win 2675.64 -11.51% 130% 30%

2600.00 -14.01% 100% 0%

2500.00 -17.32% 100% 0%

2400.00 -20.63% 100% 0%

Risk-Return Analysis: SSE Index -Linked Note

100%

130%

2675.6

Principal

Index3023.7

⍟As long as the SSE index >2675.64, our product offers 30% bonus. If the index decreases, we provide 100% protection.

Page 11: UBS Project Presentation

USD 100% Capital Protected

USDCHF–Linked Note

General Terms

Issuer United Bank of Switzerland

Denomination USD 200,000 per Note

Notional Amount USD 100,000,000

Number of Notes 500 Notes

Issue Price 100% of the Notional Amount

Issue Date 20 April 2016

Maturity Date 19 April 2021

Underlying Currency Exchange Rate of Swiss Franc against US Dollar

Initial Rate 1.049, USDCHF Spot Rate

Final RateSpot Rate Observed through Trades at 10 a.m., New York City Time at Maturity Date

Option Type Up–and–Out Call Spread

Barrier Level 1.300

Final Redemption100% + {Max(XT-0.921 , 0)/0.921 - Max(XT-1.2 , 0)/0.921}

Min Redemption 100%

Summary of indicative terms and conditions as of 8 April

2016

Page 12: UBS Project Presentation

Prospects :USDCHF –Linked Note

Inflation Rate Comparison

US Increasing Interest Rate

Demand of a Safe Haven

Page 13: UBS Project Presentation

  USD/CHF Chg% Principal Return

  1.300 23.97% 130.25% 5.43%

  1.289 22.89% 130.25% 5.43%

  1.249 19.07% 130.25% 5.43%

  1.209 15.26% 130.25% 5.43%

  1.169 11.44% 126.84% 4.87%

  1.129 7.63% 122.50% 4.14%

  1.089 3.81% 118.16% 3.39%

Current 1.049 0.00% 113.81% 2.62%

  1.009 -3.81% 109.47% 1.83%

⍟Breakeven 0.976 -6.97% 105.88% 1.15%

  0.969 -7.63% 105.13% 1.01%

  0.929 -11.44% 100.79% 0.16%

  0.921 -12.17% 100.00% 0.00%

Risk-Return Analysis: USDCHF –Linked Note

100%

130%

0.921

Principal

FX Rate

106%

1.200 1.300

⍟When the USD/CHF > 0.976, the annualized return is 1.15%, which is equal to US 5-year swap rate.

Page 14: UBS Project Presentation

RUB 100% Capital Protected

DAX-Linked Note

General Terms

Issuer United Bank of Switzerland

Denomination RUB 250,000 per Note

Notional Amount RUB 100,000,000

Number of Notes 400 Notes

Issue Price 100% of the Notional Amount

Issue Date 20 April 2016

Maturity Date 19 April 2021

Underlying Index Deutsche Boerse AG German Stock Index 

Index Initial Level 9,761.47

Index Final Level Closing Level of the Index on Maturity Date

Option Type Quanto Call Option

Strike Level 6166.6

Final Redemption 100%+ Max(0,DAX-6166.6)/6166.6

Min Redemption 100%

Summary of indicative terms and conditions as of 12 April

2016

Page 15: UBS Project Presentation

Prospects :DAX –Linked Note

Russian swap rate is high

DAX has a moderate performance

Page 16: UBS Project Presentation

Risk-Return Analysis: DAX –Linked Note

100%

211%

6166.6

Principal

Index

162%

  DAX Chg% Principal Return

  13278.84 36.03% 215.34% 16.58%

12992.52 33.10% 210.69% 16.07%

  12071.67 23.67% 195.76% 14.38%

  11811.38 21.00% 191.54% 13.88%

  10974.25 12.42% 177.96% 12.22%

  10737.62 10.00% 174.13% 11.73%

⍟Breakeven 9976.59 2.20% 161.78% 10.10%

Current 9761.47 0.00% 158.30% 9.62%

  8785.32 -10.00% 142.47% 7.34%

  7906.79 -19.00% 128.22% 5.10%

  7116.11 -27.10% 115.40% 2.91%

  6404.50 -34.39% 103.86% 0.76%

  6166.60 -36.83% 100.00% 0.00%

5764.05 -40.95% 100% 0.00%

⍟When the DAX increases by 2.20% to 9976.59, the annualized return is 10.10%, which is equal to Russian 5-year swap rate.

Page 17: UBS Project Presentation

BRL 80% Capital Protected

PFE -Linked Note (Quanto Adjusted)

General Terms

Issuer United Bank of Switzerland

Denomination BRL 250,000 per Note

Notional Amount BRL 100,000,000

Number of Notes 400 Notes

Issue Price 100%

Issue Date 20 April 2016

Maturity Date 19 April 2019

Underlying Stock Pfizer Inc. (PFE)

Initial Price 32.00

Final Price Closing Price of the Stock on Maturity Date

Option Type Fixed Lookback Call

Strike Level 30.62

Final Redemption 80%+ 3*Max(PFEmax-30.62,0)/30.62

Min Redemption 80%

Summary of indicative terms and conditions as of 12 April

2016

Page 18: UBS Project Presentation

Prospects : PFE –Linked Note

High dividend yield and low volatility

Structure Renovation

Deep pipeline andcost-cutting initiatives

Page 19: UBS Project Presentation

Risk-Return Analysis: PFE –Linked Note

80%

130%

32.8

Principal

Smax

100%

103%

  Max Price Chg% Principal Bonus

  47.131 47.29% 241.70% 141.70%

  45.319 41.62% 223.94% 123.94%

  43.575 36.17% 206.87% 106.87%

  41.900 30.94% 190.45% 90.45%

  40.288 25.90% 174.66% 74.66%

  38.206 19.39% 154.26% 54.26%

  37.368 16.78% 146.06% 46.06%

  34.611 8.16% 119.05% 19.05%

⍟Win 32.978 3.06% 103.06% 3.06%

Current 32.000 0.00% 93.47% -6.53%

30.720 -4.00% 80.93% -19.07%

  29.491 -7.84% 80.00% -20.00%

28.312 -11.53% 80.00% -20.00%

⍟During the investment period, as long as Pfizer price is higher that 32.978, our product will outperform the stock.

Page 20: UBS Project Presentation

Thank you! ( ' ' )●◡●Q&A

Page 21: UBS Project Presentation

Vanilla Bond

Maturity 5

Settlement 04/09/16

Maturity 04/08/21

Frequency 1

Swap 2.1375%

Subsidy 0.15%

Subsidy 0.704%

Leverage 3

FIX 2.31%

Value FIX 2.47%

Floor 1.73%

Cost Floor 0.7669%

Profit 1.00%

Appendix: Leveraged FRN on Australian Dollar

Page 22: UBS Project Presentation

Vanilla Bond

Maturity 5

Settlement 04/12/16

Maturity 04/11/21

Frequency 1

Swap 8.250%

Subsidy 0.15%

Subsidy 0.59%

Leverage 2

FIX 7.99%

Value FIX 3.07%

Cap 11.99%

Cost Cap 1.4706%

Profit 1.0000%

Appendix: Leveraged Inverse FRN on South Africa Rand

Page 23: UBS Project Presentation

Appendix: CNY 100% Capital Protected SSE Composite Index-Linked Note

Profit Margin

Bond 88.01%

Option 10.99%

Cost 99.00%

Profit 1.00%

Digital Option

Index 3023.65

Strike 2675.64

Bonus 30.0%

Term 5

Rate 2.87%

Vol 35.83%

Dividend Yield 2.02%

Digital Call 0.366

Cost 10.99%

Vanilla Bond

Maturity 5

Settlement 04/12/16

Maturity 04/11/21

Coupon 0.00%

Principal 100.00%

Freq 1

Swap 2.75%

Subsidy 0.15%

Cost 88.01%

Page 24: UBS Project Presentation

Appendix: USD 100% Capital Protected USDCHF –Linked Note

Vanilla Bond

Maturity 5

Settlement 04/09/16

Maturity 04/08/21

Coupon 0.00%

Principal 100.00%

Freq 1

Swap 1.15%

Subsidy 0.15%

Cost 95.18%

Barrier Option

FX 1.049

Strike 0.921

Barrier 1.300

Term 5

Rate 1.70%

Bid Vol 11.80%

Dividend Yield -0.36%

Knock-out Call 3.904%

Leverage 1

Strike 1.200

Barrier 1.300

Offer Vol 11.80%

Knock-out Call 0.0794%

Cost 3.825%

Profit Margin

Bond 95.18%

Option 3.82%

Cost 99.00%

Profit 1.00%

Page 25: UBS Project Presentation

Vanilla Bond

Maturity 5

Settlement 04/12/16

Maturity 04/11/21

Coupon 0.00%

Principal 100.00%

Frequency 1

Swap 10.10%

Subsidy 0.15%

Cost 62.39%

Quanto Adjustment

  RUS DAX

Index 9761.47

Strike 9761.47

Term 5

Volatility 20.42%

FX Volatility 23.56%

Correlation 0.49

Risk-free Rate 9.24% 0.165%

Dividend Yield 9.939% 3.24%

Expt Growth -0.699% -3.075%

Quanto Call

Index 9761.47

Strike 6166.60

Term 5

Rate 9.24%

Dividend Yield 9.94%

Bid Vol 20.42%

Quanto 2257.34

Cost 0.3661

Appendix: RUB 100% Capital Protected DAX Index-Linked Note

Profit Margin

Bond 62.39%

Option 36.61%

Cost 99.00%

Profit 1.00%

Page 26: UBS Project Presentation

Appendix: BRL 80% Capital Protected Pfizer Stock Price-Linked Note

Vanilla Bond

Maturity 3

Settlement 04/12/16

Maturity 04/11/19

Coupon 0.00%

Principal 80.00%

Freq 1

Swap 13.46%

Subsidy 0.15%

Cost 55.13%

Floating Lookback Option

Price 32.00

Strike 30.62

Term 3

Rate 1.70%

Bid Vol 17.44%

Div Yld 15.545%

Lookback Call 4.48

Leverage 3

Cost 43.869%

Profit Margin

Bond 55.13%

Option 44.869%

Cost 99.00%

Profit 1.00%

Quanto Adjustment

  BRZ PFE

Index 32

Strike 32

Term 3

FX Volatility  23.073%

Correlation  0.05

Volatility 17.44%

Risk-Free Rate 13.68% 1.700%

Dividend Yield 15.545% 3.75%

Expt Growth -1.865% -2.050%